Home Infusion Therapy Market - By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharma) & Forecast, 2023-2032

Home Infusion Therapy Market Size

Home Infusion Therapy Market size was worth more than USD 28.5 billion in 2022 and is anticipated to exhibit 11% CAGR from 2023-2032.
 

The high prevalence of hospital-acquired infections has elevated the demand for home infusion therapy devices in recent years. Unhygienic practices, non-sterile environments, and negligence of infection control procedures have intensified the cases of infections caused by fungal, viral, and bacterial pathogens in healthcare facilities.
 

Catheter-associated urinary tract infections (CAUTI) are one of the most common types of healthcare-associated infection that can be linked to using of unclean healthcare equipment and facilities. According to the data provided by the Stryker Corporation, nearly 449,334 cases of CAUTI are reported each year in the U.S. This scenario represents lucrative scope for home infusion therapy equipment providers in the forthcoming period.
 

Growing safety concerns associated with home infusion therapy devices that are procured from local players may impede home infusion therapy market statistics. These devices showcase a certain risk of failure and safety issues for both patients and caregivers during administration. The U.S. Food and Drug Administration (FDA) has reported a myriad of challenges with infusion pumps, including software defects, damaged mechanical parts, performance failures, inadequate user interface design, and battery failures. The high risk of complications associated with these devices could negatively impact product sales.
 

Home Infusion Therapy Market Analysis

Home infusion therapy market from the infusion pumps segment is anticipated to reach USD 39.5 billion by 2032. Diabetes is a growing concern across developed economies. According to the World Health Organization (WHO), incidences of diabetes have been rising over the last decade, with nearly 422 million cases in 2021. Infusion pumps enable at-home administration of drugs including insulin, nutrients, fluids, antibiotics, and other medications in controlled dosages. Increasing incidences of diabetes due to fast-paced lifestyles and unhealthy dietary habits will accelerate the need for advanced insulin pumps.
 

Home infusion therapy market from the anti-infective application segment is projected to expand at over 10.5% CAGR between 2023 and 2032. Anti-infective home infusion therapy is commonly prescribed to patients with ailments like chronic urinary tract infections (UTIs). As per data published by the American Urology Foundation, in 2021, around 8 million individuals in the U.S. consulted physicians for chronic UTIs. Growing concerns associated with infectious diseases such as cellulitis, abscesses, pneumonia, and catheter sepsis will further boost product uptake across healthcare facilities.
 

North America home infusion therapy market is poised to surpass USD 30 billion by 2032. The region is expected to witness robust demand for home infusion therapy services owing to rising incidences of chronic diseases. A large patient pool of Alzheimer’s disease will fuel the need for home infusion pumps in countries such as the U.S. and Canada. Additionally, the presence of leading industry players will showcase lucrative scope for technological advancements and the development of innovative therapy in the region. U.S. home infusion therapy industry is poised to depict over 10% CAGR through 2023-2032.
 

Home Infusion Therapy Market Share

Some of the leading companies in the home infusion therapy market include

• B. Braun Melsungen AG
• Baxter International Inc.
• Becton Dickinson and Company
• Fresenius Kabi
• ICU Medical Inc.
• Terumo Corporation
• Moog Inc.
• Halyard Health, Inc. (Avanos Medical)
• Amsino International, Inc.
• Lepu Medical Technology
• Erenler Medikal
• Contec Medical Systems Co. Ltd
• JMS Co. Ltd.

These companies are focusing on the development and commercialization of innovative healthcare products. For instance, in March 2022, Fresenius Kabi’s Wireless Agilia Connect Infusion System was granted the U.S. FDA 510(k) Clearance. The system ensures the centralized distribution of custom drug libraries and the warehousing of infusion data for reporting and analysis.
 

COVID-19 Impact

The COVID-19 pandemic had a positive impact on the home infusion therapy industry due to the increasing efforts of healthcare practitioners to provide optimal patient treatment at home. Rising pressure on healthcare facilities during the pandemic led to the accelerated adoption of home nutritional infusion therapies that enable virtual consultation and at-home diagnosis. The pandemic further propelled patient inclination toward at-home medical devices and equipment, thereby influencing the industry outlook.
 

The home infusion therapy market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product

• Infusion pumps
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

By Application

• Anti-Infective
• Hydration Therapy
• Chemotherapy
• Enteral Nutrition
• Parenteral Nutrition
• Speciality Pharmaceuticals
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico 
• Middle East & Africa
• South Africa